107 results on '"Carotenuto, Mario"'
Search Results
2. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
3. Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis
4. Vaccination Against Influenza in Multiple Myeloma
5. CFU-GM are not increased in peripheral blood of patients with chronic lymphocytic leukaemia
6. RECOMBINANT ERYTHROPOIETIN FOR MYELODYSPLASTIC SYNDROMES
7. Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia
8. PROPHYLAXIS AGAINST INFECTIONS WITH INTRAVENOUS IMMUNOGLOBULINS IN MULTIPLE MYELOMA
9. Preventing Fungal Infection in Neutropenic Patients with Acute Leukemia: Fluconazole Compared with Oral Amphotericin B
10. Soluble transferrin receptor in beta-thalassaemia
11. A prospective study of residual-disease monitoring of theALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia
12. Immunocytochemical typing of fine needle aspirates by means of alkaline phosphatase anti-alkaline phosphatase method. A study of 16 selected patients
13. Comportamento nelle 24 ore della risposta insulinemica ad un costante e ripetuto carico di glucosio in soggetti normali
14. Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis
15. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
16. PROPHYLAXIS AGAINST INFECTIONS WITH INTRAVENOUS IMMUN0GLOBULINS IN MULTIPLE MYELOMA
17. A Dysfunctional Factor X (Factor X San Giovanni Rotondo) Present at Homozygous and Double Heterozygous Level: Identification of a Novel Microdeletion (delC556) and Missense Mutation (Lys408→Asn) in the Factor X Gene
18. Treatment of “Poor Risk” Acute Myeloid Leukemia with Fludarabine, Cytarabine and G-CSF (Flag Regimen): A Single Center Study
19. Expansion of hematogones in a patient with gaucher disease
20. CD38 Expression Correlates with Adverse Biological Features and Predicts Poor Clinical Outcome in B-Cell Chronic Lymphocytic Leukemia
21. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders
22. Chronic Lymphoproliferative Disorders: An Integrated Point of View for the Differential Diagnosis
23. Minimally Differentiated Acute Myeloid Leukemia (AML M0): Clinico-Biological Findings of 29 Cases
24. Inability of Activated Cord Blood T Lymphocytes to Perform Th1-like and Th2-like Responses: Implications for Transplantation
25. Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies
26. Serum Level of the Soluble Form of the CD30 Molecule Identifies Patients With Hodgkin's Disease at High Risk of Unfavorable Outcome
27. Identification of chromosome changes in acute myeloid leukemia (AML-M2) by molecular cytogenetics
28. An “all‐oral” combination therapy in chronic lymphocytic leukemia including the oral idarubicin
29. An “all-oral” combination therapy in chronic lymphocytic leukemia including the oral ldarubicin
30. Are “Early” and “Late” T-Acute Lymphoblastic Leukemias Different Diseases? A Single Center Study of 34 Patients
31. ProMECE-CytaBOM vs MACOP-B in Advanced Aggressive Non-Hodgkin's Lymphoma: Long Term Results of a Multicenter Study of the Italian Lymphoma Study Group (GISL)
32. SPONTANEOUS REMISSION IN ACUTE MYELOID LEUKAEMIA: A ROLE FOR ENDOGENOUS PRODUCTIONOF TUMOUR NECROSIS FACTOR AND INTERLEUKIN‐2?
33. Plasma Cell Acid Phosphatase and Prognosis in Multiple Myeloma
34. Exacerbation of porokeratosis: A sign of immunodepression
35. Increased Risk of Neurological Relapse in Acute Lymphoblastic Leukemias with High Levels of Cerebrospinal Fluid Thymidine Kinase at Diagnosis
36. Nodular Lesions of the Liver in Multiple Myeloma: A Role for Cytoadhesion Molecules?
37. TREATMENT OF PLASMA CELL LEUKAEMIA AND RESISTANT/RELAPSED MULTIPLE MYELOMA WITH VINCRISTINE, MITOXANTRONE AND DEXAMETHASONE (VMD PROTOCOL)
38. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission
39. Cutaneous Presentation of Acute Myeloid Leukemia in a « Classical » Kaposi's Sarcoma Patient
40. Clinical Relevance of Immunocytochemical Detection of Multidrug-Resistance-Associated P-Glycoprotein in Hematologic Malignancies
41. CD38 Expression Correlates with Adverse Biological Features and Predicts Poor Clinical Outcome in B-Cell Chronic Lymphocytic Leukemia.
42. Significance and limits of cerebrospinal fluid beta-2-microglobulin measurement in course of acute lymphoblastic leukemia.
43. Long-Term Results From MOPPEBVCAD Chemotherapy With Optional Limited Radiotherapy in Advanced Hodgkin's Disease
44. Serum Beta2-Microglobulin in Malignant Lymphoproliferative Disorders
45. Salerno Quadrante. N.1-3 (1955)
46. Hepatitis C Virus Infection: A New Bridge Between Hematologists and Gastroenterologists?
47. Soluble Intercellular Adhesion Molecule-1 Correlates With Markers of Disease Activity in B-Cell Chronic Lymphocytic Leukemia
48. Granulocyte Colony-Stimulating Factor and Erythropoietin for the Anemia of Myelodysplastic Syndromes: A Real Improvement With Respect to Erythropoietin Alone?
49. Tetraploidy (92,XXYY) in an acute nonlymphocytic leukemia (M1) patient following autologous bone marrow transplantation
50. Inefficacy of clarithromycin in advanced multiple myeloma: a definitive report.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.